Supra Pacific Management Consultancy Ltd

Supra Pacific has shown significant growth in net sales, increasing from 0.30 Cr in March 2019 to 47.42 Cr in March 2025, with operating profit improving to 5.75 Cr. However, the company faces challenges with rising liabilities and negative cash flow, resulting in a closing cash balance of -1.00 Cr.

On 27 Nov, Supra Pacific Management Consultancy Ltd's shares continued their downward trajectory, closing at ₹27.78 with a decline of 0.39%, reflecting ongoing investor caution and weak price momentum against a broadly positive market backdrop.

As of November 17, 2025, Supra Pacific's valuation has improved to attractive, indicating it is currently undervalued with a PE ratio of 25.61 and strong growth potential compared to peers like Bajaj Finance and Life Insurance, while also having outperformed the Sensex over three years despite recent short-term underperformance.

Supra Pacific has experienced significant growth in net sales, increasing from 0.05 Cr in March 2020 to 47.42 Cr in March 2025, alongside improved profitability, with profit after tax rising from a loss of 0.09 Cr to 1.14 Cr. However, the company faces challenges with rising debt and negative cash flow, indicating ongoing cash generation issues.

As of November 10, 2025, Supra Pacific is fairly valued with a PE ratio of 41.98, an EV to EBITDA of 10.88, and a PEG ratio of 0.71, indicating growth potential, but its year-to-date decline of 10.59% contrasts with the Sensex's gain of 6.91%, suggesting a need for reevaluation against peers like Bajaj Finance and SBI Life Insurance.

The next results date for Supra Pacific is 14 November 2025.

As of November 7, 2025, Supra Pacific is considered overvalued with a PE ratio of 41.68, an EV to EBITDA of 10.86, and a PEG ratio of 0.71, especially when compared to peers like Bajaj Finance and Life Insurance, and has underperformed the Sensex with a return of -4.75%.

As of November 7, 2025, Supra Pacific is considered overvalued with a PE ratio of 41.68 and an EV to EBITDA of 10.86, especially when compared to peers like Bajaj Finserv and Life Insurance, and its year-to-date return of -11.24% further indicates a decline relative to the Sensex's 6.50% gain.

As of November 7, 2025, Supra Pacific is considered overvalued with a PE ratio of 41.68, significantly higher than its peers, and has underperformed the market, indicating a shift in valuation from fair to expensive.

As of November 6, 2025, Supra Pacific is fairly valued with a PE Ratio of 40.54, an EV to EBITDA of 10.77, and a PEG Ratio of 0.69, despite underperforming the Sensex with a year-to-date return of -13.65%.

As of November 4, 2025, Supra Pacific is considered overvalued with a PE ratio of 41.98, an EV to EBITDA of 10.88, and a PEG ratio of 0.71, especially when compared to peers like Bajaj Finance and Life Insurance, and it has underperformed the Sensex with a year-to-date return of -10.59%.

As of November 4, 2025, Supra Pacific is considered overvalued with a PE ratio of 41.98, lagging behind the Sensex with a year-to-date return of -10.59%, while its peers show more attractive valuations.

Supra Pacific has experienced substantial growth from March 2021 to March 2025, with net sales rising from 1.69 Cr to 47.42 Cr and operating profit turning positive at 5.75 Cr. However, total liabilities increased significantly, indicating higher debt levels despite positive trends in profitability.

Supra Pacific has experienced significant growth in net sales and profit from March 2021 to March 2025, with net sales rising from 1.69 Cr to 47.42 Cr and profit after tax increasing from 0.10 Cr to 1.14 Cr. However, the company faces challenges with high interest expenses and negative cash flow from operating activities despite its growth.

As of October 23, 2025, Supra Pacific is fairly valued with a PE Ratio of 42.34, an EV to EBITDA of 10.91, and a PEG Ratio of 0.72, positioning it competitively within the NBFC sector despite a year-to-date return of -9.81% compared to the Sensex's 8.21%.

As of 23-Oct, Supra Pacific Management Consultancy Ltd is priced at 29.13, showing a slight rise but trading below key moving averages, indicating a bearish trend. Despite a recent increase in investor participation, the stock has underperformed significantly compared to the Sensex, with notable declines over the past week and year-to-date.

Supra Pacific has experienced significant growth in net sales, rising from 0.05 Cr in Mar'20 to 47.42 Cr in Mar'25, and improved profitability, with profit after tax increasing from a loss of 0.09 Cr to a profit of 1.14 Cr. However, the company faces challenges with rising debt and negative cash flow from operations.